Navigation Links
Red Cross Promotes Prevention, Control of TB Along U.S. - Mexican Border

WASHINGTON, While the global health community and residents of several countries are concerned about news reports of the estimated 100 people who may have contracted tuberculosis (TB) from an infected airplane passenger recently, the American Red Cross has been working for two years along the U.S. and Mexican border to prevent the spread of this particularly infectious disease.

At a conference held in Matamoros, Mexico in May, senior representatives from both the American and the Mexican Red Cross came together to discuss greater cooperation in local border communities, as well as at the international level, in health promotion.

Lance Leverenz, the regional director for the Americas for the American Red Cross, emphasizes that the success of such an initiative is contingent upon his organization's role as an international actor.

"Such challenges require solutions that transcend national boundaries," said Leverenz. "The International Red Cross and Red Crescent Movement is uniquely positioned to confront these issues."

In Matamoros -- across the border from Brownsville, Texas -- vital services provided by the Red Cross reach deep into the community to encourage care-seeking behaviors, reduce the stigma associated with TB, and most importantly, get people into treatment and see treatment through to a successful cure.

Since its inception in June 2005, the TB treatment program has increased the number of patients who complete the six-month treatment regimen from 78 percent to 86 percent, a treatment rate higher than the United Nations World Health Organization target. The Red Cross utilizes health care systems that are flexible in meeting the needs of each community.

Although the two-year pilot project focuses on reducing the incidence of TB, similar strategies can be applied to preventing the spread of HIV/AIDS, preparing disaster response programs, and promoting humanitarian values. '"/>




Page: 1 2

Related medicine news :

1. FDA attacks American Red Cross for blood violations
2. Encephalitis Death Toll In U.P. Crosses 200 Mark.
3. Encephalitis Deaths Cross 220 in Uttar Pradesh
4. First Crossover Kidney Transplantation In Germany
5. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
6. Red Cross Says Fund Boost and Awareness Are the Main Ingredients to Fight AIDS
7. Salutations For The Selfless Heroes On World Red Cross Day
8. Waxing And Waning Of Dengue Epidemics Attributed To Cross-Immunity
9. Viruses Can Cross Species Barrier
10. American Red Cross Fined by FDA over Blood Collection Practices
11. American Red Cross Fined $4.2m for Improper Blood Screening
Post Your Comments:
(Date:7/25/2008)...on Significant Improvements in Members, Health, A... leader in health,care quality management solution...it has entered into a long-term agreement with Wel...aboration on Quality(SM) Incent and,Reward Best Pr...rk and,primary care clinicians to promote improved...
(Date:7/25/2008)...ire/ -- The Elekta Family of Companies will,showca... at the 2008,American Association of Physicists in... the joint forces of Elekta, IMPAC and CMS are del...d delivery solutions that,streamline the treatment...s, as well as enhance clinician efficiency., "Our...
(Date:7/25/2008)...esophagus can cause immune system changes , ...t evidence linking gastroesophageal reflux disease...versity Medical Center researchers. , An associ...n the 1970s, and since then studies have shown tha...ents also experience GERD symptoms. But the actual...
(Date:7/25/2008)... Retina Group of New York will present an educatio...tion especially designed for seniors. The lecture ...116 Merritts Road, Farmingdale, NY 11735, 1:00 to ... and refreshments will be provided. The phone numb... Hicksville and Hauppauge, NY (...
Breaking Medicine News(10 mins):Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3
...y subsided by administering sweet to children now ...ell Chemical Senses Center.// They have reported t...enced both by how much a child likes sweet taste a.... This appears in the Journal Pain. "Some children...
...arian Roger Williams has called for a ban on an ar... production of 6,000 types of medicines, food and ... that the sweetener, which is used in cereal, choc...mazzini Foundation has published reports that aspa...
...ple afflicted with the Alzheimer's disease is expe...ongevity and the population explosion in developin...from dementia which is connected to cardiovascular... this figure is expected to rise to 42 million, an...
..., produced by the state-owned Hindustan Latex Ltd....t cities.// 'For the past year we had test markete...ry and from the excellent response from both men a...enter the market. This would now be available in a...
Other Medicine News:Health News:Sweet pain releiver! 2
(Date:7/24/2008)...July 24 /- Alexza,Pharmaceu... it has initiated,its second Phase 3 clinical tria... inhalation product candidate being developed for ...schizophrenia or bipolar disorder.,Alexza believes...kinetic,(PK) properties resulting from inhaled lox...
(Date:7/24/2008)...er designed to take body temperature, for home,and...FirstCall/ --- Kidz-Med, Inc.,(subsidiary of Ameri...United States distributor of the Thermofocus(R) 5-...ce the results of a clinical study,conducted by th...lan, in,Milan, Italy, which proves that the Thermo...
(Date:7/23/2008)...ublication in July print edition of Clinical ...ANAPOLIS, July 23 /- A Roche Diagnost...terminal pro-B-type natriuretic peptide,(NT-proBNP...sk,stratification in predicting the risk of cardio...d with non-steroidal anti-inflammatory drugs of,th...
(Date:7/23/2008)...reas of the Body Have Greater Concentrations of,St...swire-USNewswire/ -- Fat removed,from the lower ab...d to be,an excellent source of stem cells, with hi...the body, reports a Brazilian-based study in Augus...icial medical journal of the,American Society of P...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 1Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 2Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 3Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 4Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 5Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 6Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 7Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 8Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 9Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 10In early childhood continuous care by 1 doctor improves delivery of health screenings 13217 1In early childhood continuous care by 1 doctor improves delivery of health screenings 13217 2FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 1FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 2FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 3FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 4FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 5Short RNA strand helps exposed skin cells protect body from bacteria dehydration and even cancer 13210 1Short RNA strand helps exposed skin cells protect body from bacteria dehydration and even cancer 13210 2Short RNA strand helps exposed skin cells protect body from bacteria dehydration and even cancer 13210 3
...CO, July 10, 2007 /PRNewswire/ -- Portola,Pharmace...its lead,compound, PRT054021, an oral Factor Xa in...ional Society on Thrombosis and Haemostasis,(ISTH)...hat,PRT054021 was safe, effective, and well tolera...ents (VTE) in patients,undergoing total knee repla...
..., N.J.--(BUSINESS WIRE)--Jul 11, 2007 - Since the ...ine (NEJM) report,that Avandia users are 43 percen...ent more likely to die of cardiovascular causes,th...ysicians intend,to switch many type 2 diabetes pat...ess risk. Research from GfK Market Measures,Event...
Other Medicine Technology:Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 2Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 3Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 4Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures 2Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures 3
... FoamWrap ACTION Elbow Wrap replaces messy taping ..., and others experiencing epicondylitis. Preferred...nd non-bulky fit. Two overlay straps allow you to ...m lining holds the Elbow Wrap comfortably in place...
The Bledsoe Extender Arm Brace is designed to handle post-op elbow arthroscopy, severe elbow strains and ligament trauma. The Bledsoe Extender Arm Brace should be used when limited R.O.M. or locked c
...s controlled stretch ankle support helps reduce sw... of motion. It is easy to apply - it slips on lik...es. It features bilateral spiral stays that move ...nd stability. This is an excellent support for li...
...s lightweight ankle splint may be used for either ... It is effective in stabilizing the ankle joint f...removal. The rigid pre-bent metal stays are adjus... The stays also help the splint control rotational...
Medicine Products: